Ionizing radiation inhibits chemotherapy-induced apoptosis in cultured glioma cells: Implications for combined modality therapy

Cancer Research

Volumn 58, Issue 17, 1998, Pages 3819-3825

  Yount, Garret L ^a   Haas Kogan, Daphne A ^a   Levine, Kiera S ^a   Aldape, Ken D ^a   Israel, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM TUMOR; DOSE TIME EFFECT RELATION; DRUG CYTOTOXICITY; GLIOMA CELL; HUMAN; HUMAN CELL; IONIZING RADIATION; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; TUMOR SUPPRESSOR GENE; X RAY;

ANTIGENS, CD95; APOPTOSIS; CISPLATIN; COMBINED MODALITY THERAPY; G1 PHASE; GLIOBLASTOMA; HUMANS; TUMOR CELLS, CULTURED;

EID: 0032169976     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Levin, V. A., Gutin, P. H., and Leibel, S. Neoplasms of the central nervous system. In: V. T. De Vita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer Principles and Practice of Oncology, pp. 1679-1737. Philadelphia: J. B. Lippincott Co., 1993.
2. Leibel, S. A., and Sheline, G. E. Radiation therapy for neoplasms of the brain. J. Neurosurg., 66: 1-22, 1987.
3. Kleihues, P., Burger, P. C., and Scheithauer, B. W. Histological Typing of Tumors of the Central Nervous System, pp. 14-22. Berlin: Springer-Verlag, 1993.
4. Wallner, K. E., Galicich, J. H., and Krol, G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytomas. Int. J. Radiat. Oncol. Biol. Phys., 16: 1405-1409, 1989.
5. Taghian, A., Suit, H., Pardo, F., Gioioso, D., Tomkinson, K., DuBois, W., and Gerweck, L. In vitro intrinsic radiation sensitivity of glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys., 23: 55-62, 1992.
6. Yang, X., Darling, J. L., McMillan, T. J., Peacock, J. H., and Steel, G. G. Radiosensitivity, recovery and dose-rate effect in three human glioma cell lines. Radiother. Oncol., 19: 40-56, 1990.
7. Gerweck, L. E., Kornblith, P. L., Burlett, P., Wang, J., and Sweigert, S. Radiation sensitivity of cultured human glioblastoma cells. Radiology, 125: 231-234, 1977.
8. Chang, C. H., Horton, J., Schoenfeld, D., Salazer, O., Perez-Tamayo, R., Kramer, S., Weinstein, A., Nelson, J. S., and Tsukada, Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group Study. Cancer (Phila.), 52: 997-1007, 1983.
9. Green, D. M., Thomas, P. R., and Shochat, S. The treatment of Wilms' tumor. Results of the National Wilms' Tumor Studies. Hematol. Oncol. Clin. N. Am., 9: 1267-1274, 1995.
10. Goldwein, J. W., Radcliffe, J., Johnson, J., Moshang, T., Packer, R. J., Sutton, L. N., Rorke, L. B., and D'Angio, G. J. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int. J. Radiat. Oncol. Biol. Phys., 34: 899-904, 1996.
11. Packer, R. J., Sutton, L. N., Elterman, R., Lange, B., Goldwein, J., Nicholson, H. S., Mulne, L., Boyett, J., D'Angio, G., Wechsler-Jentzsch, K., Reaman, G., Cohen, B. H., Bruce, D. A., Rorke, L. B., Molloy, P., Ryan, J., LaFond, D., Evans, A. F., and Schut, L. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J. Neurosurg., 81: 690-698, 1994.
12. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N. Engl. J. Med., 324: 1685-1690, 1991.
13. Tester, W., Caplan, R., Heaney, J., Venner, P., Whittington, R., Byhardt, R., True, L., and Shipley, W. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group Phase II trial 8802. J. Clin. Oncol., 14: 119-126, 1996.
14. Rich, T. A., Ajani, J. A., Morrison, W. H., Ota, D., and Levin, B. Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother. Oncol., 27: 209-215, 1993.
15. Flam, M., John, M., Pajak, T. F., Petrelli, N., Myerson, R., Doggett, S., Quivey, J., Rotman, M., Kerman, H., Coia, L., and Murray, K. Role of mitomycin in combination with fluorouracil and radiotherapy and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a Phase III randomized intergroup study. J. Clin. Oncol., 14: 2527-2539, 1996.
16. Aleman, B. M., Bartelink, H., and Gunderson, L. L. The current role of radiotherapy in colorectal cancer. Eur. J. Cancer, 31A: 1333-1339, 1995.
17. Bartelink, H., Roelofsen, F., Eschwege, F., Rougier, P., Bosset, J. F., Gonzalez, D. G., Peiffert, D., van Glabbeke, M., and Pierart, M. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a Phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J. Clin. Oncol., 15: 2040-2049, 1997.
18. Zidan, J., Kuten, A., and Robinson, E. Intensive short course chemotherapy followed by radiotherapy of locally advanced nasopharyngeal carcinoma. Cancer (Phila.), 77: 1973-1977, 1996.
19. Vokes, E. E. Combined-modality therapy of head and neck cancer. Oncology (Huntingt.), 11: 27-30, 1997.
20. Moertel, C. G., Frytak, S., Hahn, R. G., O'Connell, M. J., Reitemeier, R. J., Rubin, J., Schutt, A. J., Weiland, L. H., Childs, D. S., Holbrook, M. A., Lavin, P. T., Livstone, E., Spiro, H., Knowlton, A., Kaiser, M., Barkin, J., Lessner, H., Mann-Kaplan, R., Ramming, K., Douglas, H. O., Jr., Thomas, P., Nave, H., Bateman, J., Lokich, J., Brooks, J., Chaffey, J., Corson, J. M., Zamcheck, N., and Novak, J. W. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer (Phila.), 48: 1705-1710, 1981.
21. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer (Phila.), 59: 2006-2010, 1987.
22. Maksymiuk, A. W., Jett, J. R., Earle, J. D., Su, J. Q., Diegert, F. A., Mailliard, J. A., Kardinal, C. G., Krook, J. E., Veeder, M. H., Wiesenfeld, M., Tschetter, L. K., and Levitt, R. Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial. J. Clin. Oncol., 12: 70-76, 1994.
23. Komaki, R., Shin, D. M., Glisson, B. S., Fossella, F. V., Murphy, W. K., Garden, A. S., Oswald, M. J., Hong, W. K., Roth, J. A., Peters, L. J., Holoye, P. V., and Ellerbroek, N. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys., 31: 807-811, 1995.
24. Recht, A., Come, S. E., Henderson, I. C., Gelman, R. S., Silver, B., Hayes, D. F., Shulman, L. N., and Harris, J. R. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N. Engl. J. Med., 334: 1356-1361, 1996.
25. Davis, L. W. Presidential address: malignant glioma. A nemesis which requires clinical and basic investigation in radiation oncology. Int. J. Radiat. Oncol. Biol. Phys., 16: 1255-1256, 1988.
26. Weller, M., Frei, K., Groscurth, P., Krammer, P. H., Yonekawa, Y., and Fontana, A. Anti-FAS/APO-1 antibody-mediated apoptosis of cultured human glioma cells. J. Clin. Investig., 94: 954-964, 1994.
27. Cleveland, J. L., and Ihle, J. N. Contenders in FasL/TNF death signaling. Cell, 81: 479-482, 1995.
28. Yount, G. L., Haas-Kogan, D. A., Vidair, C. A., Haas, M., Dewey, W. C., and Israel, M. A. Cell cycle synchrony unmasks the influence of p53 on radiosensitivity of human glioblastoma cells. Cancer Res., 56: 500-506, 1996.
29. Hsiao, M., Low, J., Dorn, E., Ku, D., Pattengale, P., Yeargin, J., and Haas, M. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness. Am. J. Pathol., 145: 702-714, 1994.
30. Murphy, S. Generation of astrocyte cultures from normal and neoplastic central nervous system. In: P. M. Conn (ed.), Methods in Neurosciences: Cell Culture, pp. 33-47. San Diego, CA: Academic Press, 1990.
31. Kondo, S., Barna, B. P., Morimura, T., Takeuchi, J., Yuan, J., Akbasak, A., and Barnett, G. H. Interleukin-1β-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells. Cancer Res., 55: 6166-6171, 1995.
32. Aoshima, J., Kubota, M., Nishimura, T., and Iwamura, T. DNA polymerases of Chlorella. II. Characterization to distinguish the two enzymes. J. Biochem. (Tokyo), 96: 461-473, 1984.
33. Fine, H. A., Dear, K. B. G., Loeffler, J. S., Black, P. M., and Canellos, G. P. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer (Phila.), 8: 2585-2597, 1993.
34. Joss, R. A., Alberto, P., Bleher, E. A., Ludwig, C., Siegenthaler, P., Martinelli, G., Sauter, C., Schatzmann, E., and Senn, H. J. Combined-modality treatment of small-cell lung cancer: randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest. Ann. Oncol., 5: 921-928, 1994.
35. International Nasopharynx Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy versus radiotherapy alone in stage IV (> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. VUMCAI trial. Int. J. Radiat. Oncol. Biol. Phys., 35: 463-469, 1996.
36. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumor suppressor gene. Nature (Lond.), 351: 453-456, 1991.
37. Schlapbach, R., and Fontana, A. Differential activity of bcl-2 and ICE enzyme family protease inhibitors on Fas and puromycin-induced apoptosis of glioma cells. Biochim. Biophys. Acta, 1359: 174-180, 1997.
38. Wang, C. Y., Mayo, M. W., and Baldwin, A. S., Jr. TNF-and cancer therapy-induced apoptosis. Potentiation by inhibition of NF-κB. Science (Washington DC), 274: 784-787, 1996.
39. Kroemer, G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med., 3: 614-620, 1997.
40. Eichholtz-Wirth, H. Reversal of radiation-induced cisplatin resistance in murine fibrosarcoma cells by selective modulation of the cyclic GMP-dependent transduction pathway. Br. J. Cancer, 72: 287-292, 1995.
41. Taghian, A., Gioioso, D., Budach, W., and Suit, H. In vitro split-dose recovery of glioblastoma multiforme. Radiat. Res., 134: 16-21, 1993.
42. Halperin, E. C. Multiple-fraction-per-day external beam radiotherapy for adults with supratentorial malignant gliomas. J. Neuro-Oncol., 14: 255-262, 1992.